Chris Robinson, DO, MS - Research

Research at a glance

Top areas of exploration

Subarachnoid Hemorrhage , 2 publications
Analgesics , 1 publications
Headache , 1 publications
Narcotics , 1 publications

Research activity

17 publications

73 citations

Focus

Dr. Robinson's research interests include traumatic brain injury, coagulation abnormalities in neurologic disease, subarachnoid hemorrhage, and simulation based training in neurologic disease.

Active clinical trials

Bio-BOOST

BioBOOST is a multicenter, observational study of the effect of derangements in brain physiologic parameters on brain injury biomarker levels in patients with severe traumatic brain injury.

Investigator: Chris Robinson
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

BOOST3

BOOST3 is a randomized clinical trial to determine the comparative effectiveness of two strategies for monitoring and treating patients with traumatic brain injury (TBI) in the intensive care unit (ICU). The study will determine the safety and鈥�

Investigator: Chris Robinson
Status: Accepting Candidates
Ages: 14 Years - N/A
Sexes: All

My publications

17 publications

2021

Pterygopalatine Fossa Blockade as Novel, Narcotic-Sparing Treatment for Headache in Patients with Spontaneous Subarachnoid Hemorrhage.

Neurocritical care

鈥�

2020

Clinical Reasoning: A 45-year-old man with progressive insomnia and psychiatric and motor symptoms.

Neurology

鈥�

2020

Neurologic Manifestations of Severe Respiratory Viral Contagions.

Critical care explorations

鈥�

2020

Successful Use of Tissue Plasminogen Activator for Saddle Pulmonary Embolism in Perimesencephalic Nonaneurysmal Subarachnoid Hemorrhage.

World neurosurgery

鈥�

2019

Meningitis and encephalitis management in the ICU.

Current opinion in critical care

鈥�

网红黑料